Cartesian Therapeutics Inc (NAS:RNAC)
$ 35.77 -0.23 (-0.64%) Market Cap: 636.56 Mil Enterprise Value: 545.21 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 50/100

Q4 2021 Selecta Biosciences Inc Earnings Call Transcript

Mar 10, 2022 / 01:30PM GMT
Release Date Price: $52.5
Operator

Good morning, and welcome to the Selecta Biosciences Fourth Quarter and Full Year 2021 Financial Results and Corporate Update Conference Call. (Operator Instructions) This call is being webcast live on the Investors and Media section of Selecta's website at www.selectabio.com, and it is being recorded.

For opening remarks, I would like to introduce Kevin Tan, Chief Financial Officer of Selecta. Please go ahead.

Kevin Tan
Selecta Biosciences, Inc. - CFO

Thank you, and good morning. Welcome to our fourth quarter and full year 2021 financial results and corporate update conference call. The press release reporting our financial results is available in the Investors and Media section of Selecta's website worldwide web, selectabio.com, and our annual report on Form 10-K for the year ended December 31, 2021, which will be filed today with the Securities and Exchange Commission, or SEC.

Joining me today are Carsten Brunn, President and Chief Executive Officer; and Peter Traber,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot